Marvin Samson, Director at ANTARES PHARMA, INC. (ATRS), bought 50,000 shares at $0.72 ($36K) on 2016-03-18, disclosed to the SEC on 2016-03-21.
Open-market purchase of $36k ATRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2019-12-26 | $707K | — | Filing → |
| ATRS | BUY | 2014-08-12 | $50K | — | Filing → |